TPM3 and breast cancer: As expected, the invasive ability of MDA231 cells was sharply enhanced because of the platelet‐releasing microvesicles from patients with BC (Fig. 4E,F), whereas the up‐regulation of invasive activity was attenuated by silencing TPM3 with siRNAs (Fig. 4E,F).